Tumour budding in colorectal cancer: molecular rationale for clinical translation

Nature Reviews Cancer 18, 203 (2018).
doi:10.1038/nrc.2018.1

Authors: Inti Zlobec & Alessandro Lugli
Precision medicine and personalized health care call for reproducible and standardized predictive and prognostic biomarkers that can influence the clinical management of patients with cancer. In colorectal cancer, tumour budding — a histological manifestation of tumour cell invasion that is likened to epithelial–mesenchymal transition — is now emerging as one such factor.

Source: Nature Reviews Cancer - January 29, 2018 Category: Cancer & Oncology Authors: Inti Zlobec Alessandro Lugli Tags: Comment Source Type: research